Skip to main content
Clinical Trials/NCT04821115
NCT04821115CompletedNot Applicable

Safety and Efficacy of Low-intensity Shockwave Therapy for Peyronie's Disease

Hopital Foch8 sites in 1 country120 target enrollmentStarted: April 6, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
120
Locations
8
Primary Endpoint
Effect of low intensity ESWT on penile curvature in erection in patients with Peyronie's disease

Study Overview

Brief Summary

Investigation of the effect of Low-intensity extracorporeal shockwave therapy (ESWT) for Peyronie's disease (PD) via a single blind, sham-controlled, randomized clinical trial. Investigators will not be blinded to group assignments, but penile curvature will be assessed from coded patient pictures by a blinded assessor.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • ≥18 years old male,
  • Untreated Peyronie's disease (excepted oral therapy) (wash out: at least 1 month),
  • Single axis penile curvature in erection at 20 - 90 degrees at baseline,
  • Dorsal or lateral penile plaque,
  • Able and willing to perform ESWT self-treatment under supervision,
  • Able to understand and complete patient questionnaires,
  • Having sign an informed consent form prior to any study specific procedure,
  • Being covered by a national health insurance

Exclusion Criteria

  • Congenital penile deformity,
  • Hourglass deformity,
  • Circumferential plaque,
  • Septal or ventral plaque,
  • Plaque that cannot be palpated during clinical examination,
  • Previous intralesional injection for Peyronie's Disease,
  • Severe erectile dysfunction (EHS < 3),
  • Current penile, malignancy,
  • Previous penile surgery except for circumcision or condyloma removal,
  • Previous pelvic radiation therapy,
  • Anti-coagulant medication, except acetylsalicylic acid up to 100mg daily,
  • Previous low-intensity focused shockwave therapy on penis,
  • Any other condition that would prevent the patient from completing the study, as judged by the principal investigator,
  • Being deprived of liberty or under guardianship.

Outcomes

Primary Outcomes

Effect of low intensity ESWT on penile curvature in erection in patients with Peyronie's disease

Time Frame: 15 months

Average change in penile curvature based on the pictures taken by the patient (face and profil) at baseline and after the 6 week follow-up. The assessment will be performed by a blinded assessor at the end of the study

Secondary Outcomes

  • Assessment of the safety of ESWT on patients with PD: adverse events(3 months)
  • Assessment of the effect of ESWT on penile pain(3 months)
  • Assessment of the effect of ESWT on sexual bother(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (8)

Loading locations...

Similar Trials